Ads

 

Ads

 

Ads

 

World Top 100 Biotechnology Companies List by Market Cap in January 2024

World Top 100 Biotechnology Companies List by Market Cap in January 2024, World Biggest 100 Biotechnology Companies by Market Cap, World Largest 100 Biotechnology Companies in the World by market cap as pf Jan-05-2024.

Metatag Title
World Top Biotechnology Companies in 2024
Metatag Abstract
World Largest Biotechnology Companies by Market Cap in 2024, World Top Biotechnology Companies by Market Cap in 2024.
  1. Reata Pharmaceuticals

    World Rank (Jan-05-2024)
    2,443
    World Rank (Jul-30-2023)
    2,443
    Market Cap (Jul-30-2023)
    6.278 Billion USD
    World Rank (Dec-25-2022)
    7,125
    Market Cap (Dec-25-2022)
    1.319 Billion USD
    World Rank (Jan-07-2022)
    9,134
    Market Cap (Jan-07-2022)
    1.05 Billion USD
    Annual Revenue in USD
    2 Million USD
    Annual Operating Income in USD
    -278 Million USD
    Annual Net Income in USD
    -311 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile

    Reata Pharmaceuticals is a Bio-pharmaceutical company with headquarters is in Texas, USA.

    Biogen acquired Reata Pharmaceuticals for 7.3 Billion USD in 2023.

  2. SK Biopharmaceuticals

    World Rank (Jan-05-2024)
    2,458
    Market Cap (Jan-05-2024)
    6.236 Billion USD
    World Rank (Jul-30-2023)
    2,963
    Market Cap (Jul-30-2023)
    5.022 Billion USD
    World Rank (Dec-25-2022)
    3,068
    Market Cap (Dec-25-2022)
    4.349 Billion USD
    World Rank (Jan-07-2022)
    2,773
    Market Cap (Jan-07-2022)
    6.17 Billion USD
    Annual Revenue in USD
    189 Million USD
    Annual Operating Income in USD
    -101 Million USD
    Annual Net Income in USD
    -107 Million USD
    Annual Results for Period Ending
    Dec-2022 ending period
    Headquarters Country
    Company Profile

    SK Biopharmaceuticals is a Biopharmaceutical company that develops new drugs in support of innovations in the medical field. The headquarters is in South Korea.

  3. Vaxcyte Inc.

    World Rank (Jan-05-2024)
    2,495
    Market Cap (Jan-05-2024)
    6.122 Billion USD
    World Rank (Jul-30-2023)
    3,324
    Market Cap (Jul-30-2023)
    4.376 Billion USD
    World Rank (Dec-25-2022)
    3,506
    Market Cap (Dec-25-2022)
    3.686 Billion USD
    World Rank (Jan-07-2022)
    8,241
    Market Cap (Jan-07-2022)
    1.26 Billion USD
    Annual Revenue in USD
    0 Million USD
    Annual Operating Income in USD
    -207 Million USD
    Annual Net Income in USD
    -223 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile

    Vaxcyte is a Biotechnology company developing potentially superior and novel vaccines designed to prevent or treat the most common and deadly infectious diseases worldwide. It is having 43 employees as on 2019. The headquarters is in USA.

  4. Masimo Corporation

    World Rank (Jan-05-2024)
    2,602
    Market Cap (Jan-05-2024)
    5.816 Billion USD
    World Rank (Jul-30-2023)
    2,371
    Market Cap (Jul-30-2023)
    6.505 Billion USD
    World Rank (Dec-25-2022)
    1,879
    Market Cap (Dec-25-2022)
    7.784 Billion USD
    World Rank (Jan-07-2022)
    1,433
    Market Cap (Jan-07-2022)
    14.03 Billion USD
    Annual Revenue in USD
    2,035 Million USD
    Annual Net Income in USD
    143 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    CEO
    Company Profile

    MASIMO CORPORATION is Medical devices manufacturing company with headquarters is in California, USA.

  5. Eidos Therapeutics

    World Rank (Jan-05-2024)
    2,624
    World Rank (Jul-30-2023)
    2,624
    World Rank (Dec-25-2022)
    2,624
    World Rank (Jan-07-2022)
    2,624
    Headquarters Country
    Company Profile

    Eidos Therapeutics is a Biopharmaceutical company with headquarters is in California, USA.

    Eidos Therapeutics was acquired by BridgeBio Pharma Inc in 2021.

     

  6. Immunovant

    World Rank (Jan-05-2024)
    2,674
    Market Cap (Jan-05-2024)
    5.626 Billion USD
    World Rank (Jul-30-2023)
    4,418
    Market Cap (Jul-30-2023)
    2.942 Billion USD
    World Rank (Dec-25-2022)
    7,090
    Market Cap (Dec-25-2022)
    1.328 Billion USD
    World Rank (Jan-07-2022)
    9,880
    Market Cap (Jan-07-2022)
    0.92 Billion USD
    Annual Revenue in USD
    0 Million USD
    Annual Net Income in USD
    -156 Million USD
    Annual Results for Period Ending
    Mar-2022 ending year
    Headquarters Country
    Company Profile
    Immunovant is a Clinical Stage Biopharmaceutical company. It is focused on enabling normal lives for patients with autoimmune diseases. The headquarters is in USA.
  7. Shijiazhuang Yiling Pharmaceutical

    World Rank (Jan-05-2024)
    2,708
    Market Cap (Jan-05-2024)
    5.516 Billion USD
    World Rank (Jul-30-2023)
    2,616
    Market Cap (Jul-30-2023)
    5.789 Billion USD
    World Rank (Dec-25-2022)
    1,724
    Market Cap (Dec-25-2022)
    8.643 Billion USD
    World Rank (Jan-07-2022)
    2,931
    Market Cap (Jan-07-2022)
    5.77 Billion USD
    Annual Revenue in USD
    1,756 Million USD
    Annual Operating Income in USD
    416 Million USD
    Annual Net Income in USD
    331 Million USD
    Annual Results for Period Ending
    Dec-2022 ending period
    Headquarters Country
    Company Profile
    Shijiazhuang Yiling Pharmaceutical is a Leading Enterprise of Internalization of Preparation of Chinese Pharmaceutical Enterprise company. The company annual revenue is 885.04 million USD and 9,618 employees as on 2019. It is having more than 10 national patent Chinese medicine, 13 clinic permissions, over 20 preclinical permissions and hundreds of hospital preparations, covering major diseases fields as cardiovascular and cerebrovascular diseases, cold and respiratory diseases, tumors and diabetes. The headquarters is in China.
  8. Hualan Biological Engineering

    World Rank (Jan-05-2024)
    2,715
    Market Cap (Jan-05-2024)
    5.501 Billion USD
    World Rank (Jul-30-2023)
    2,567
    Market Cap (Jul-30-2023)
    5.908 Billion USD
    World Rank (Dec-25-2022)
    2,562
    Market Cap (Dec-25-2022)
    5.408 Billion USD
    World Rank (Jan-07-2022)
    2,153
    Market Cap (Jan-07-2022)
    8.42 Billion USD
    Annual Revenue in USD
    633 Million USD
    Annual Operating Income in USD
    209 Million USD
    Annual Net Income in USD
    151 Million USD
    Annual Results for Period Ending
    Dec-2022 ending period
    Headquarters Country
    Company Profile
    Biopharmaceutical company with headquarters is in China.
  9. Asymchem Laboratories (Tianjin)

    World Rank (Jan-05-2024)
    2,720
    Market Cap (Jan-05-2024)
    5.496 Billion USD
    World Rank (Jul-30-2023)
    2,458
    Market Cap (Jul-30-2023)
    6.228 Billion USD
    World Rank (Dec-25-2022)
    2,100
    Market Cap (Dec-25-2022)
    6.769 Billion USD
    World Rank (Jan-07-2022)
    1,418
    Market Cap (Jan-07-2022)
    14.21 Billion USD
    Annual Revenue in USD
    1,437 Million USD
    Annual Operating Income in USD
    445 Million USD
    Annual Net Income in USD
    463 Million USD
    Annual Results for Period Ending
    Dec-2022 ending period
    Headquarters Country
    Company Profile
    Asymchem is a Pharmaceutical company. The company range from early clinical stage to commercial stage including R&D (Research and development) and cGMP(Current Good Manufacturing Practice) production of advanced intermediates, APIs (Application Programming Interface), formulations as well as clinical research services. It is having 3,840 employees as on 2019. The headquarters is in China.
  10. Iveric Bio

    World Rank (Jan-05-2024)
    2,731
    World Rank (Jul-30-2023)
    2,731
    Market Cap (Jul-30-2023)
    5.510 Billion USD
    World Rank (Dec-25-2022)
    4,099
    Market Cap (Dec-25-2022)
    2.983 Billion USD
    World Rank (Jan-07-2022)
    7,176
    Market Cap (Jan-07-2022)
    1.61 Billion USD
    Annual Operating Income in USD
    -189 Million USD
    Annual Net Income in USD
    -185 Million USD
    Annual Results for Period Ending
    Dec-2022 ending period
    Headquarters Country
    Company Profile

    Iveric Bio is an Innovative Biopharmaceutical company focused on the discovery and development of treatments for retinal diseases with significant unmet medical needs. Iveric Bio 163 employees as on 2022. The headquarters is in USA.

    Astellas Pharma Inc. (TSE: 4503) has completed the acquisition of IVERIC bio, Inc. (NASDAQ: ISEE) on July 11, 2023 and the acquisition price of the same was 5.9 billion USD.

Share

Ads